“Xero” stems from the Greek word xēros, meaning “dry”

The market for products to control sweating is large and highly underpenetrated by prescription pharmaceutical products.

We strive to improve the quality of life of patients suffering from primary axillary hyperhidrosis, or excessive underarm sweating.

About

Xero Pharmaceuticals is a clinical stage specialty pharmaceutical company that strives to improve the quality of life of patients suffering from primary axillary hyperhidrosis, or excessive underarm sweating.

Research

NT-077 is a repurposed medicine that we are currently developing as a potential best-in-class, self-administered, once-daily, topical therapy for the treatment of primary axillary hyperhidrosis, or excessive underarm sweating.

Therapeutic area

The market for products to control sweating is large and highly underpenetrated by prescription pharmaceutical products. More specifically, of the patients who seek treatment from a physician

Application System

Since NT-077 spray solution is a consumer product, we are convinced that the functional design of the container/closure systems including pump heads and applicators for dermatological products is of great clinical concern.

News

Carduso Capital invests in start-up Xero Pharmaceuticals that develops an innovative remedy for excessive sweating.

Contact

We’re here to help and answer any question you might have about our research on the topical application of NT-077 spray solution in the treatment of axillary hyperhidrosis. We look forward to hearing from you!